The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients. We have more ideas, we see more opportunities and we want to help more patients.
In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core.
Headquartered near Basel, Switzerland – a bona fide European biotech hub – Idorsia is specialized in the discovery and development of small molecules to provide innovative therapeutic possibilities.
With its US Commercial Operations based in Philadelphia, PA, Idorsia is committed to meet the changing needs of healthcare professionals, patients and their families. The core of what we do is to bring creative solutions to the market based on our science and data.
We have identified five key strategic priorities to ensure the company’s success over the first five years.
Idorsia’s corporate responsibility efforts encompass employee development and diversity, governance and ethics, as well as the organization’s economic, environmental, and social performance.
It’s the Idorsia team’s passion for science that will translate our objectives into value creation for all our stakeholders.
Research & Development
Idorsia aims to deliver new products with the potential to significantly change the treatment options in their target diseases.